Monitor viral load and CD4 cell counts at baseline and with modification of ARV treatment.
Perform hepatitis C antibody testing prior to initiation or modification of ARV treatment.
Test for hepatitis B virus (HBV) infection prior to or during initiation as severe acute exacerbation may occur upon therapy discontinuation.
Monitor ALT, AST, total bilirubin, and urinalysis at baseline and with modification of ARV treatment.
Obtain fasting blood glucose or HbA1C, fasting lipid profile, and CBC with a differential.
Obtain estimate CrCl, serum phosphorus, and urinalysis.
Obtain basic chemistry including serum sodium, potassium, bicarbonate, chloride, BUN, creatinine, and creatinine-based estimated glomerular filtration rate.